106 related articles for article (PubMed ID: 3068033)
41. Photosensitization of MCF-7 cells with diaziquone using visible light: correlation with DNA strand breaks and free radical production.
al-Nabulsi I; Gutierrez PL
Photochem Photobiol; 1992 Aug; 56(2):201-9. PubMed ID: 1502264
[TBL] [Abstract][Full Text] [Related]
42. Redox cycles of caffeic acid, alpha-tocopherol, and ascorbate: implications for protection of low-density lipoproteins against oxidation.
Laranjinha J; Cadenas E
IUBMB Life; 1999 Jul; 48(1):57-65. PubMed ID: 10791916
[TBL] [Abstract][Full Text] [Related]
43. Fully reversible redox cycling of 2,6-dimethoxy-1,4-benzoquinone induced by ascorbate.
Roginsky VA; Bruchelt G; Stegmann HB
Biochemistry (Mosc); 1998 Feb; 63(2):200-6. PubMed ID: 9526115
[TBL] [Abstract][Full Text] [Related]
44. DNA adducts of the antitumor agent diaziquone.
Gupta RC; Garg A; Earley K; Agarwal SC; Lambert GR; Nesnow S
Cancer Res; 1991 Oct; 51(19):5198-204. PubMed ID: 1913643
[TBL] [Abstract][Full Text] [Related]
45. Oxidative metabolism of combretastatin A-1 produces quinone intermediates with the potential to bind to nucleophiles and to enhance oxidative stress via free radicals.
Folkes LK; Christlieb M; Madej E; Stratford MR; Wardman P
Chem Res Toxicol; 2007 Dec; 20(12):1885-94. PubMed ID: 17941699
[TBL] [Abstract][Full Text] [Related]
46. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma.
Ross D; Siegel D; Gibson NW; Pacheco D; Thomas DJ; Reasor M; Wierda D
Free Radic Res Commun; 1990; 8(4-6):373-81. PubMed ID: 2113030
[TBL] [Abstract][Full Text] [Related]
47. Stopped flow ESR study of the action of carbohydrates on ascorbic acid oxidation in aqueous solution.
Kalus WH; Filby WG
Int J Vitam Nutr Res; 1985; 55(1):85-9. PubMed ID: 2987149
[TBL] [Abstract][Full Text] [Related]
48. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
[TBL] [Abstract][Full Text] [Related]
49. Diaziquone (AZQ).
Bender JF; Grillo-Lopez AJ; Posada JG
Invest New Drugs; 1983; 1(1):71-84. PubMed ID: 6381377
[TBL] [Abstract][Full Text] [Related]
50. Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas.
Curt GA; Kelley JA; Kufta CV; Smith BH; Kornblith PL; Young RC; Collins JM
Cancer Res; 1983 Dec; 43(12 Pt 1):6102-5. PubMed ID: 6640549
[TBL] [Abstract][Full Text] [Related]
51. Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986).
Savaraj N; Lu K; Feun LG; Leavens ME; Stewart D; Burgess MA; Benjamin RS; Loo TL
J Neurooncol; 1983; 1(1):15-9. PubMed ID: 6678302
[TBL] [Abstract][Full Text] [Related]
52. Vitamin E slows the rate of free radical-mediated lipid peroxidation in cells.
Wagner BA; Buettner GR; Burns CP
Arch Biochem Biophys; 1996 Oct; 334(2):261-7. PubMed ID: 8900400
[TBL] [Abstract][Full Text] [Related]
53. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
Tannock I
Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
[TBL] [Abstract][Full Text] [Related]
54. Differential cytotoxicity of diaziquone toward Chinese hamster ovary cells under hypoxic and aerobic exposure conditions.
O'Brien PJ; Kaul HK; Rauth AM
Cancer Res; 1990 Mar; 50(5):1516-20. PubMed ID: 2302714
[TBL] [Abstract][Full Text] [Related]
55. Phase I study of diaziquone.
Frytak S; Eagan RT; Ames MM; Creagan ET; Nichols WC
Cancer Treat Rep; 1984; 68(7-8):975-8. PubMed ID: 6744349
[TBL] [Abstract][Full Text] [Related]
56. Diaziquone-induced cytotoxicity in isolated rat hepatocytes.
Silva JM; O'Brien PJ
Cancer Res; 1989 Oct; 49(20):5550-4. PubMed ID: 2790779
[TBL] [Abstract][Full Text] [Related]
57. The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles.
Feun LG; Savaraj N; Lu K; Guo Z; Raulston LG; Benjamin RS; Fields WS; Loo TL
J Neurooncol; 1983; 1(3):219-24. PubMed ID: 6678971
[TBL] [Abstract][Full Text] [Related]
58. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
King CL; Wong SK; Loo TL
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
[TBL] [Abstract][Full Text] [Related]
59. Membrane lipid free radicals produced from L1210 murine leukemia cells by photofrin photosensitization: an electron paramagnetic resonance spin trapping study.
Buettner GR; Kelley EE; Burns CP
Cancer Res; 1993 Aug; 53(16):3670-3. PubMed ID: 8393378
[TBL] [Abstract][Full Text] [Related]
60. Survival and cell cycle kinetics responses of Chinese hamster ovary cells, and clones of human adenocarcinoma of the stomach and astrocytoma to diaziquone (AZQ) in vitro.
Barranco SC; Schechter GA; Boerwinkle WR; Howell KA; Rubin NH
Invest New Drugs; 1983; 1(1):11-9. PubMed ID: 6678853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
